Kalaris Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$12 | −$11 | −$12 | −$11 | −$10 | −$38 | −$5.7 | −$3.4 | |
| −$0.48 | −$0.46 | −$0.64 | −$0.61 | −$2.52 | −$28.16 | −$4.26 | −$2.60 | |
| 24 | 24 | 19 | 19 | 4.1 | — | — | — |
Trend